Evidence map›Paper›PMID 35505442›Full record

ArticleAlzheimer's research & therapy2022

Comparative analysis of machine learning algorithms for multi-syndrome classification of neurodegenerative syndromes.

Leonie Lampe, Sebastian Niehaus, Hans-Jürgen Huppertz, Alberto Merola, Janis Reinelt, Karsten Mueller, Sarah Anderl-Straub, Klaus Fassbender, Klaus Fliessbach, Holger Jahn and 20 more

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Detection of parkinson's disease with neuroimaging modalities using machine learning and artificial intelligence: a systematic review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Leonie Lampe *AICURA Medical GmbH, Berlin, Germany. leonie.lampe@aicura-medical.com.
Sebastian Niehaus *AICURA Medical GmbH, Berlin, Germany.
Hans-Jürgen HuppertzSwiss Epilepsy Clinic, Klinik Lengg, Zurich, Switzerland.
Alberto MerolaAICURA Medical GmbH, Berlin, Germany.
Janis ReineltAICURA Medical GmbH, Berlin, Germany.
Karsten MuellerMax Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.
Sarah Anderl-StraubDepartment of Neurology, University of Ulm, Ulm, Germany.
Klaus FassbenderDepartment of Neurology, Saarland University, Homburg, Germany.
Klaus FliessbachClinic for Neurodegenerative Diseases and Geriatric Psychiatry, German Center for Neurodegenerative Diseases (DZNE), University of Bonn, Bonn, Germany.
Holger JahnClinic for Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Johannes KornhuberDepartment of Psychiatry and Psychotherapy, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany.
Martin LauerDepartment of Psychiatry and Psychotherapy, University Wuerzburg, Würzburg, Germany.
Johannes PrudloDepartment of Neurology, DZNE, University of Rostock, Rostock, Germany.
Anja SchneiderClinic for Neurodegenerative Diseases and Geriatric Psychiatry, German Center for Neurodegenerative Diseases (DZNE), University of Bonn, Bonn, Germany.
Matthis SynofzikDepartment of Neurodegenerative Diseases, Centre for Neurology & Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tübingen, Germany.
Adrian DanekDepartment of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.
Janine Diehl-SchmidDepartment of Psychiatry and Psychotherapy, Technical University of Munich, Munich, Germany.
Markus OttoDepartment of Neurology, University of Ulm, Ulm, Germany.
FTLD-Consortium Germany
Arno VillringerClinic for Cognitive Neurology, University Clinic Leipzig, Leipzig, Germany.
Karl EggerDepartment of Neuroradiology, University Hospital of Freiburg, Freiburg, Germany.
Elke HattingenDepartment of Neuroradiology, University Hospital of Frankfurt, Frankfurt, Germany.
Rüdiger Hilker-RoggendorfDepartment of Neurology, Klinikum Vest, Recklinghausen, Germany.
Alfons SchnitzlerInstitute of Clinical Neurosciences and Medical Psychology, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.
Martin SüdmeyerInstitute of Clinical Neurosciences and Medical Psychology, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.
Wolfgang OertelDepartment of Neurology, Philips-University Marburg, Marburg, Germany.
German Atypical Parkinson Consortium Study Group
Jan KassubekDepartment of Neurology, University of Ulm, Ulm, Germany.
Günter HöglingerDepartment of Neurology, Technical University of Munich, Munich, Germany.
Matthias L SchroeterClinic for Cognitive Neurology, University Clinic Leipzig, Leipzig, Germany. schroet@cbs.mpg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

importanceThe entry of artificial intelligence into medicine is pending. Several methods have been used for the predictions of structured neuroimaging data, yet nobody compared them in this context.

objectiveMulti-class prediction is key for building computational aid systems for differential diagnosis. We compared support vector machine, random forest, gradient boosting, and deep feed-forward neural networks for the classification of different neurodegenerative syndromes based on structural magnetic resonance imaging. DESIGN, SETTING, AND

participantsAtlas-based volumetry was performed on multi-centric T1-weighted MRI data from 940 subjects, i.e., 124 healthy controls and 816 patients with ten different neurodegenerative diseases, leading to a multi-diagnostic multi-class classification task with eleven different classes.

interventionsN.A. MAIN OUTCOMES AND MEASURES: Cohen's kappa, accuracy, and F1-score to assess model performance.

resultsOverall, the neural network produced both the best performance measures and the most robust results. The smaller classes however were better classified by either the ensemble learning methods or the support vector machine, while performance measures for small classes were comparatively low, as expected. Diseases with regionally specific and pronounced atrophy patterns were generally better classified than diseases with widespread and rather weak atrophy. CONCLUSIONS AND RELEVANCE: Our study furthermore underlines the necessity of larger data sets but also calls for a careful consideration of different machine learning methods that can handle the type of data and the classification task best.

Indexed as

Artificial IntelligenceMachine LearningAlgorithmsAtrophyHumansSyndromeComparative analysisDeep neural networkGradient boostingMulti-syndrome classificationNeurodegenerative syndromesRandom forestSupport vector machine

Identifiers

PMID35505442
PMCPMC9066923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.